XML 31 R14.htm IDEA: XBRL DOCUMENT

Related Party Transactions

12 Months Ended

Jan. 31, 2019

Related Party Transactions [Abstract]

RELATED PARTY TRANSACTIONS

8.	RELATED PARTY TRANSACTIONS

a)

An interest-free advance from the mother of the chief executive officer was $10,230 at January 31, 2018. The advance was repaid in full May 2018.

b)

During the year ended January 31, 2018, the chief financial officer advanced $8,250 to the Company, all of which was paid as of January 31, 2018. Additionally, the chief financial officer made payments on behalf of the Company during the year ended January 31, 2019 in the total amount of $30,800 and $4,000 in 2018, all of which was repaid in May 2018.

c)

The former owner of 4P Therapeutics has been a director of the Company since April 2018, when the Company entered into an agreement to acquire 4P Therapeutics. See Note 6 in connection with the terms of the acquisition of 4P Therapeutics from the former owner and the royalty payable to the former. The former owner was not a director of the Company when the acquisition agreement was signed.

d)

During the year ended January 31, 2019, the Company issued 210,000 shares of common stock, valued at $967,500, to executives of the Company based on the market price of the common stock on the date of issuance.

e)

During the year ended January 31, 2019, the Company issued 5,000 shares of common stock to each of the Company's six independent directors for a total of 30,000 shares valued at $222,000, based on the market price on the date of issuance.